imminent...

A lot was made by ACL mgmt of the 6 month GIVE initiative. But even a little research at the time (which I didn't do) would have revealed the long, long delays being experienced by the FDA. Did mgmt not know or were they as uninformed as I was? Then, when we had all waited so long it got painful, they indicated December 2010. Nope, never happened. Not even close. Moreover, notwithstanding some info that came to us late, we were told in every company presentation that we were likely to be the only generic. Wrong again.
Throughout all of this, when we were all twiddling our fingers waiting for approval, it appears that mgmnt was too. The stage three trial could have been started a couple of years ago (with either dilution or a partnership, something I was in favour of at the time) and we would now be getting the results and, all going well, gearing up for big revenues and two years ahead of any competition. Instead we are still trying to get together the funding. By September, or a slight slip into October we were told very recently - nope, it appears not. Now it seems December. Few here will be holding their breath, I'm sure.
All the while the sp has gone nowhere. Who would have guessed 30odd cents at this point in time? Not a single one of us. Now, don't get me wrong I'm a fan of the opportunities that ACL offers, and I was lucky enough to get in during the GFC so I'm still showing an okay profit, but surely we must be starting to ask mgmt a few serious questions? Can we really look at this and think it has all been handled well? Not by my way of thinking.
I'm hanging in here, and ACL makes up a significant portion of my portfolio, but I can't say I'm too impressed with how things have gone - and continue to go.
That's just my view, of course. I don't post often, and I hope the next one is celebration of the skyrocketing sp.
I really hope it is. I trust all of you are well.
-j